- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Mo | British patients risking "fake" weight loss drugs, despite safety concerns, survey says | ||
| Mo | Boehringer Ingelheim launches AI centre in London | ||
| Mo | Trump backs psychedelics for mental health in new executive order | ||
| Mo | UCB to purchase Neurona and NRTX-1001 for $1.15bn | ||
| Mo | MSD secures EC approval for Enflonsia to prevent infant RSV infection | ||
| Fr | Kailera makes history with record-breaking $625m IPO | ||
| Fr | Aligos and Xiamen Amoytop sign deal for HBV therapy | ||
| Fr | Daiichi Sankyo and Interna partner for MNM-targeted delivery solutions | ||
| Do | Developers back Alzheimer's drugs despite report suggesting lack of efficacy | ||
| Do | Lilly debuts more Foundayo data as FDA requests post-marketing trials | ||
| Do | Terremoto wins $108m in Series C to drive cancer and rare disease programmes | ||
| Do | Nucleai and Sirona Dx to provide new proteomics solution for pharma companies | ||
| Do | Boehringer Ingelheim and Zai Lab team up for dual DLL3 therapy study | ||
| Mi | FDA shares guide on genome editing best practices | ||
| Mi | Amazon launches AI drug discovery platform | ||
| Mi | J&J sets the tone for Q1 earnings with strong oncology growth | ||
| Mi | Adcendo secures $75m in Series C funding for ADC development | ||
| Mi | Lilly to acquire CrossBridge Bio for up to $300m | ||
| 14.04. | EU sees 2025 pharma export uptick amid competitiveness concerns | ||
| 14.04. | Pharma 5.0, Sustainability & Security: PHARMAP 2026 brings pharma's future into focus | ||
| 14.04. | Travere Therapeutics gains FDA approval for sparsentan in FSGS | ||
| 14.04. | Novo Nordisk and OpenAI forge alliance to drive speedy drug development | ||
| 14.04. | MSD, Daiichi Sankyo's ifinatamab deruxtecan receives FDA priority | ||
| 13.04. | AbbVie bets on Chinese biopharma's pain pipeline in $745m bid | ||
| 13.04. | Telix and Regeneron to co-develop radiopharmaceutical therapies |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.